POZEN INC Contracts & Agreements

AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER AND ARRANGEMENT (Filed With SEC on December 8, 2015)

AMENDMENT NO. 2 TO AGREEMENT AND PLAN OF MERGER AND ARRANGEMENT (Filed With SEC on December 8, 2015)

SECOND AMENDED AND RESTATED FACILITY AGREEMENT (Filed With SEC on December 8, 2015)

SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 8, 2015)

AMENDED AND RESTATED SHARE SUBSCRIPTION AGREEMENT by and among ARALEZ PHARMACEUTICALS INC., ARALEZ PHARMACEUTICALS PLC, TRIBUTE PHARMACEUTICALS CANADA INC., POZEN INC., QLT INC.... (Filed With SEC on December 8, 2015)

Executive Employment Agreement between Pozen and James P. Tursi, M.D. dated September 11, 2015 (Filed With SEC on November 9, 2015)

AMENDED AND RESTATED FACILITY AGREEMENT (Filed With SEC on October 30, 2015)

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 30, 2015)

Executive Employment Agreement between Pozen and Mark Glickman dated June 22, 2015 (Filed With SEC on August 10, 2015)

Executive Employment Agreement between Pozen and Eric Trachtenberg dated June 22, 2015 (Filed With SEC on August 10, 2015)

Executive Employment Agreement between Pozen and Jennifer Armstrong dated June 22, 2015 (Filed With SEC on August 10, 2015)

Executive Employment Agreement between Pozen and Scott Charles dated July 27, 2015 (Filed With SEC on August 10, 2015)

POZEN INC. EMPLOYEE SEVERANCE PLAN AND SUMMARY PLAN DESCRIPTION JUNE 2015 (Filed With SEC on June 25, 2015)

Agreement and Plan of Merger and Arrangement, dated as of June 8, 2015, among Pozen, Tribute, Parent, Ltd2, US Merger Sub and Can Merger Sub (Filed With SEC on June 11, 2015)

Facility Agreement, dated as of June 8, 2015, among the Borrower, Pozen, Tribute and the Lenders (Filed With SEC on June 11, 2015)

Registration Rights Agreement, dated as of June 8, 2015, among Parent and the Lenders (Filed With SEC on June 11, 2015)

Share Subscription Agreement, dated as of June 8, 2015, among Pozen, Purchaser, Tribute, Parent and the Investors (Filed With SEC on June 11, 2015)

Separation and General Release Agreement between POZEN Inc. and John R. Plachetka, dated May 29, 2015 (Filed With SEC on June 3, 2015)

Voting Agreement between POZEN Inc. and John R. Plachetka, dated May 29, 2015 (Filed With SEC on June 3, 2015)

Executive Employment Agreement between POZEN Inc. and Adrian Adams dated May 31, 2015 (Filed With SEC on June 3, 2015)

Executive Employment Agreement between POZEN Inc. and Andrew Koven dated May 31, 2015 (Filed With SEC on June 3, 2015)

Termination Agreement, dated as of November 29, 2014, by and between POZEN Inc. and sanofi-aventis U.S. LLC (Filed With SEC on March 11, 2015)

Termination Agreement, dated as of January 7, 2015, by and between POZEN Inc. and Cilag GmbH International (Cilag), a division of Johnson & Johnson (Filed With SEC on March 11, 2015)

Letter Agreement, dated as of May 13, 2014, by and among POZEN Inc., CPPIB Credit Investments, Inc. Pernix Therapeutics Holdings, Inc. and Glaxo Group Limited (Filed With SEC on November 6, 2014)

First Amendment to Product Development and Commercialization Agreement, dated as of May 13, 2014, by and between POZEN Inc. and Pernix Therapeutics Holdings, Inc (Filed With SEC on November 6, 2014)

Second Amendment to Product Development and Commercialization Agreement dated as of July 30, 2014, by and between POZEN Inc. and Pernix Therapeutics Holdings, Inc (Filed With SEC on November 6, 2014)

Letter Agreement among POZEN Inc., AstraZeneca AB and Horizon Pharma U.S.A. Inc. dated as of November 18, 2013 (Filed With SEC on March 6, 2014)

Amendment No. 1 to Amended and Restated Collaboration and License Agreement for the United States by and between POZEN Inc. and Horizon Pharma U.S.A. Inc. dated as of November 18,... (Filed With SEC on March 6, 2014)

Amended and Restated Collaboration and License Agreement for the United States by and between POZEN Inc. and AstraZeneca AB dated as of November 18, 2013 (Filed With SEC on March 6, 2014)

Amended and Restated Collaboration and License Agreement for outside of the United States by and between POZEN Inc. and AstraZeneca AB dated as of November 18, 2013 (Filed With SEC on March 6, 2014)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on January 2, 2014)

First Amendment No. 3 to the Collaboration and License Agreement between POZEN Inc. and AstraZeneca AB, dated as of September 16, 2013 (Filed With SEC on November 6, 2013)

License and Collaboration Agreement between POZEN Inc. and sanofi-aventis U.S. LLC, dated as of September 3, 2013 (Filed With SEC on November 6, 2013)

First Amendment To Capital Expenditure And Equipment Agreement between Patheon Pharmaceuticals Inc., and POZEN Inc., dated as of July 10, 2013 (Filed With SEC on August 7, 2013)

First Amendment to Manufacturing Services Agreement between Patheon Pharmaceuticals Inc., and POZEN Inc., dated as of July 10, 2013 (Filed With SEC on August 7, 2013)

License and Development Agreement, dated as of May 2, 2012, by and between POZEN Inc. and Desitin Arzneimittel GmbH (Filed With SEC on August 8, 2012)

Purchase and Sale Agreement, dates as November 23, 2011, by and between POZEN Inc. and CPPIB Credit Investments Inc (Filed With SEC on March 9, 2012)

Manufacturing Services Agreement, dates as December 19, 2011, by and between POZEN Inc. and Patheon Pharmaceuticals, Inc (Filed With SEC on March 9, 2012)

Capital Expenditure and Equipment Agreement, dates as of December 19, 2011, by and between POZEN Inc. and Patheon Pharmaceuticals, Inc (Filed With SEC on March 9, 2012)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 11, 2011)

EXECUTIVEEMPLOYMENT AGREEMENT (Filed With SEC on March 9, 2010)

EXECUTIVEEMPLOYMENT AGREEMENT (Filed With SEC on December 11, 2009)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on September 14, 2009)

CONSULTINGAGREEMENT (Filed With SEC on February 24, 2009)

- 1- - (Filed With SEC on February 17, 2009)

AMENDMENTNO. 2 TO THE COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on November 4, 2008)

SECONDAMENDED AND RESTATED POZENINC. 2000 EQUITY COMPENSATION PLAN NONQUALIFIED STOCK OPTIONGRANT (Filed With SEC on May 8, 2008)

First Amendment to Second Amended and Restated Executive Employment Agreement with John R. Plachetka, dated September 28, 2007 (Filed With SEC on November 5, 2007)

First Amendment, dated September 28, 2007, to Restricted Stock Unit Agreement, dated May 4, 2004, between Registrant and John R. Plachetka (Filed With SEC on November 5, 2007)

First Amendment, dated September 28, 2007, to Restricted Stock Unit Agreement, dated February 14, 2007, between the Registrant and John R. Plachetka (Filed With SEC on November 5, 2007)

First Amendment to Long Term Incentive Cash Award Agreement, dated September 28, 2007, between the Registrant and John R. Plachetka (Filed With SEC on November 5, 2007)

First Amendment to Executive Employment Agreement with William L. Hodges, dated September 28, 2007 (Filed With SEC on November 5, 2007)

First Amendment to Executive Employment Agreement with Marshal E. Reese, Ph.D., dated September 28, 2007 (Filed With SEC on November 5, 2007)

First Amendment to Executive Employment Agreement with John E. Barnhardt, dated September 28, 2007 (Filed With SEC on November 5, 2007)

Amendment No. 1 to the Collaboration and License Agreement, dated September 6, 2007, between the Registrant and AstraZeneca, AB (Filed With SEC on November 5, 2007)

Side Letter Agreement, dated October 1, 2007, between the Registrant and AstraZeneca, AB (Filed With SEC on November 5, 2007)

SECOND AMENDED AND RESTATED POZEN INC.2000 EQUITY COMPENSATION PLAN (Filed With SEC on August 7, 2007)

SECOND AMENDED AND RESTATED POZEN INC. 2000 EQUITY COMPENSATION PLAN INCENTIVE STOCK OPTION GRANT (Filed With SEC on August 7, 2007)

SECOND AMENDED AND RESTATED POZEN INC. 2000 EQUITY COMPENSATION PLAN NONQUALIFIED STOCK OPTION GRANT (Filed With SEC on August 7, 2007)

SECOND AMENDED AND RESTATED POZEN INC. 2000 EQUITY COMPENSATION PLAN NONQUALIFIED STOCK OPTION GRANT [For Non-Employee Directors] (Filed With SEC on August 7, 2007)

SECOND AMENDED AND RESTATED POZEN INC. 2000 EQUITY COMPENSATION PLAN RESTRICTED STOCK UNIT AGREEMENT [For Non-Employee Directors] (Filed With SEC on August 7, 2007)

PROPOSAL 2 APPROVAL OF THE SECOND AMENDED AND RESTATED POZEN INC. 2000 EQUITY COMPENSATION PLAN (Filed With SEC on June 15, 2007)

CONTINGENT ANNUAL BONUS AGREEMENT (Filed With SEC on May 3, 2007)

POZEN INC. 2000 EQUITY COMPENSATION PLAN, AS AMENDED AND RESTATED (Filed With SEC on May 3, 2007)

POZEN INC. LONG TERM INCENTIVE CASH AWARD AGREEMENT (Filed With SEC on May 3, 2007)

CONTINGENT ANNUAL BONUS AGREEMENT (Filed With SEC on May 3, 2007)

POZEN INC. Summary of Director Compensation (Filed With SEC on March 8, 2007)

CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE (Filed With SEC on August 8, 2006)

SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 16, 2006)

POZEN INC. Summary of Director Compensation (Filed With SEC on March 8, 2006)

DEVELOPMENT, OPTION AND LICENSE AGREEMENT (Filed With SEC on January 11, 2006)

DEVELOPMENT, OPTION AND LICENSE AGREEMENT (Filed With SEC on July 28, 2005)

RIGHTS AGREEMENT between POZEN INC. and (Filed With SEC on January 13, 2005)

POZEN INC. (Filed With SEC on January 7, 2005)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on November 12, 2004)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 27, 2004)

POZEN INC. 2000EQUITY COMPENSATION PLAN, AS AMENDED AND RESTATED (Filed With SEC on July 30, 2004)

POZEN INC. (Filed With SEC on July 30, 2004)

RELEASE ANDSETTLEMENT AGREEMENT (Filed With SEC on May 10, 2004)

PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on August 12, 2003)

[GLAXO HEADER] June 11, 2003 (Filed With SEC on August 12, 2003)

POZEN INC. / NYCOMED DANMARK APS LICENSE AGREEMENT TABLE OF CONTENTS (Filed With SEC on August 12, 2003)

FIRSTAMENDMENT OF POZEN INC. 2000 EQUITY COMPENSATION PLAN (Filed With SEC on March 28, 2003)

Category

Industry

Companies

Contracts

POZEN INC Contracts & Agreements